Blick ins Buch

Cardiac Drugs in Pregnancy (eBook)

eBook Download: PDF

2013 | 2014
XII, 131 Seiten
Springer London (Verlag)
978-1-4471-5472-3 (ISBN)

Lese- und Medienproben

Ebook-Leseprobe (PDF)

The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition the treatment of congenital heart disease has improved leading to an increased number of women with residual heart disease reaching childbearing age. In the western world maternal heart disease is now the major cause of maternal death during pregnancy. In the developing world rheumatic heart disease and the cardiomyopathies dominate. Those women often need anticoagulation as they might have had a valve replacement or formed a thrombus in the left heart. Drugs during pregnancy and the breastfeeding period is a complex subject and there is a profound shortage of evidence based recommendations. As drug treatment in pregnancy concern the mother and the fetus optimum treatment of both must be targeted. This book aims at discussing the most important indications of drug usage in pregnancy and postpartum with the aim of weighing the potential risk of a drug and the possible benefit against each other.

Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa.

Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.

The spectrum ofcardiovascular disease affecting women in pregnancy and postpartum is changingand differs between countries. In the western world, the risk of cardiovasculardisease in pregnancy has increased due to the increasing age at the firstpregnancy and the worldwide obesity epidemic leading also to early diabetes andhypertension. In addition the treatment of congenital heart disease hasimproved leading to an increased number of women with residual heart diseasereaching childbearing age. In the western world maternal heart disease is nowthe major cause of maternal death during pregnancy. In the developing worldrheumatic heart disease and the cardiomyopathies dominate. Those women oftenneed anticoagulation as they might have had a valve replacement or formed athrombus in the left heart. Drugs during pregnancy and the breastfeeding periodis a complex subject and there is a profound shortage of evidence basedrecommendations. As drug treatment in pregnancy concern the mother and thefetus optimum treatment of both must be targeted. This book aims at discussing the most important indications of drugusage in pregnancy and postpartum with the aim of weighing the potential riskof a drug and the possible benefit against each other.

Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa.Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.

Introduction.- General principles and
guidelines.- Management of Hypertension.- Management of Heart Failure.-
Management of coronary artery
disease & Arrhythmia.- Anticoagulation in Pregnancy.- Obstetric drugs in
management if Cardiovascular disease.- Pregnancy anaesthesia in patients with
cardiovascular disease.

Erscheint lt. Verlag	22.11.2013
Reihe/Serie	Current Cardiovascular Therapy
Reihe/Serie	Current Cardiovascular Therapy
Zusatzinfo	XII, 131 p. 3 illus., 2 illus. in color.
Verlagsort	London
Sprache	englisch
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe
	Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pflege
Schlagworte	anticoagulation • maternal and child health • Maternal heart disease • pharmacotherapy • Postpartum heart disease
ISBN-10	1-4471-5472-X / 144715472X
ISBN-13	978-1-4471-5472-3 / 9781447154723

Haben Sie eine Frage zum Produkt?

PDF (Wasserzeichen)
Größe: 886 KB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Print-Ausgabe

Buch | Softcover

CHF 67,35